Pro Share Advisors LLC Catalyst Pharmaceuticals, Inc. Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 25,821 shares of CPRX stock, worth $524,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,821
Previous 26,593
2.9%
Holding current value
$524,424
Previous $644,000
13.04%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding CPRX
# of Institutions
386Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$380 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$111 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.7 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...